Yiting Lai

机构：Fujian University of Traditional Chinese Medicine, Fujian Medical University, Fujian Provincial Hospital, Union Hospital · ORCID：0009-0009-9672-6765

发表论文 6 篇 · 总被引 13 次 · h-index 2

代表论文

• Bone marrow mesenchymal stem cell–derived exosomes effectively ameliorate the outcomes of rats with acute graft‐versus‐host disease (2024 · The FASEB Journal · 被引 8)
• RBM17 promotes hepatocellular carcinoma progression by regulating lipid metabolism and immune microenvironment: implications for therapeutic targeting (2025 · Cell Death Discovery · 被引 5)
• The variable splicing factor RBM17 regulates MDS cell proliferation through H3K27la (2025 · Blood)
• MDS-603 Alternative Splicing Factor Rbm17 Affects Proliferation and Aging of MDS-HSPC (2024 · Clinical Lymphoma Myeloma & Leukemia)
• Role and Mechanism of Mesenchymal Stem Cells in Regulating the SIRT1-HNRNPA3-P53 Signaling Pathway to Improve Immune Function in Aging (2024 · Clinical Lymphoma Myeloma & Leukemia)
• CT-586 Role and Mechanism of Mesenchymal Stem Cells in Regulating the Sirt1-hnrnpa3-P53 Signaling Pathway to Improve Immune Function in Aging (2024 · Clinical Lymphoma Myeloma & Leukemia)